Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Rauch

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Virology|December 31, 2010
Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent buddingSusanne Rauch, Juan Martin-Serrano
Plos One|November 22, 2007
HIV-1 Nef employs two distinct mechanisms to modulate Lck subcellular localization and TCR induced actin remodelingClaudia Haller, Susanne Rauch, Oliver T Fackler
Journal of Virology|December 21, 2007
Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activitySusanne Rauch, Kati Pulkkinen, Kalle Saksela, et al.
Frontiers in Immunology|October 5, 2018
New Vaccine Technologies to Combat Outbreak SituationsSusanne Rauch, Edith Jasny, Kim E Schmidt, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA VaccinesSusanne Rauch, Johannes Lutz, Aleksandra Kowalczyk, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 20, 2017
mRNA Cancer VaccinesKatja Fiedler, Sandra Lazzaro, Johannes Lutz, et al.
Journal of Leukocyte Biology|December 21, 2005
Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1Oliver T Keppler, Nadine Tibroni, Stephanie Venzke, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2024
Sequence-Optimized mRNA Vaccines Against Infectious DiseaseSusanne Rauch, Johannes Lutz, Janine Mühe, et al.
NPJ Vaccines|April 17, 2021
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodentsSusanne Rauch, Nicole Roth, Kim Schwendt, et al.
NPJ Vaccines|December 21, 2023
mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodentsSandro Roier, Vidya Mangala Prasad, Monica M McNeal, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Virology|December 31, 2010
Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent buddingSusanne Rauch, Juan Martin-Serrano
Plos One|November 22, 2007
HIV-1 Nef employs two distinct mechanisms to modulate Lck subcellular localization and TCR induced actin remodelingClaudia Haller, Susanne Rauch, Oliver T Fackler
Journal of Virology|December 21, 2007
Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activitySusanne Rauch, Kati Pulkkinen, Kalle Saksela, et al.
Frontiers in Immunology|October 5, 2018
New Vaccine Technologies to Combat Outbreak SituationsSusanne Rauch, Edith Jasny, Kim E Schmidt, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA VaccinesSusanne Rauch, Johannes Lutz, Aleksandra Kowalczyk, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 20, 2017
mRNA Cancer VaccinesKatja Fiedler, Sandra Lazzaro, Johannes Lutz, et al.
Journal of Leukocyte Biology|December 21, 2005
Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1Oliver T Keppler, Nadine Tibroni, Stephanie Venzke, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2024
Sequence-Optimized mRNA Vaccines Against Infectious DiseaseSusanne Rauch, Johannes Lutz, Janine Mühe, et al.
NPJ Vaccines|April 17, 2021
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodentsSusanne Rauch, Nicole Roth, Kim Schwendt, et al.
NPJ Vaccines|December 21, 2023
mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodentsSandro Roier, Vidya Mangala Prasad, Monica M McNeal, et al.
Pageof 3